These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17388108)

  • 1. Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.
    Baou K; Vlachopoulos C; Manesis E; Archimandritis A; Stefanadis C
    Hellenic J Cardiol; 2007; 48(1):37-41. PubMed ID: 17388108
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan.
    Jiang W; Liu CH; Wu D; Wang YJ; Tang H
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34918746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?
    Yu AS; Keeffe EB
    Am J Gastroenterol; 2003 May; 98(5):955-6. PubMed ID: 12809814
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of non-alcoholic fatty liver disease on cardiovascular disease].
    Ampuero J; Romero-Gómez M
    Gastroenterol Hepatol; 2012 Oct; 35(8):585-93. PubMed ID: 22541252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome.
    Nakao H; Yoneda M
    J Gastroenterol; 2009; 44(11):1162-4. PubMed ID: 19802516
    [No Abstract]   [Full Text] [Related]  

  • 8. Population-based screening programs for nonalcoholic fatty liver disease in youth and clues to prevention.
    Manco M
    J Clin Endocrinol Metab; 2014 Mar; 99(3):774-6. PubMed ID: 24823704
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and etiology of elevated aminotransferase levels in the United States.
    Clark JM; Brancati FL; Diehl AM
    Am J Gastroenterol; 2003 May; 98(5):960-7. PubMed ID: 12809815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of serum transaminases following physical stress in patients with liver diseases].
    Zwirner K
    Acta Hepatosplenol; 1970; 17(2):97-103. PubMed ID: 5524295
    [No Abstract]   [Full Text] [Related]  

  • 12. [Non-alcoholic fatty liver disease and cardiovascular risk].
    Abel T; Fehér J
    Orv Hetil; 2008 Jul; 149(28):1299-305. PubMed ID: 18617457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-alcoholic fatty liver: 10 years' experience at the Insituto Nacional de la Nutrición Salvador Zubirán].
    de la Mora G; Olivera M; de la Cerda R; Arista J; Kershenobich D; Uribe M
    Rev Invest Clin; 1994; 46(2):85-92. PubMed ID: 8052745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver enzymes: potential cardiovascular risk markers?
    Lioudaki E; Ganotakis ES; Mikhailidis DP
    Curr Pharm Des; 2011 Nov; 17(33):3632-43. PubMed ID: 22074433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma enzyme activities in liver diseases during standardized physical exertion].
    Linneke P; Hoffmann H; Ehrke D; Lazarus P
    Z Gesamte Inn Med; 1973 Jan; 28(1):11-4. PubMed ID: 4694329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liver morphology and liver function in delirium tremens].
    Irsigler K; Kryspin-Exner K; Mildschuh W; Pointner H; Schmidt P
    Dtsch Med Wochenschr; 1971 Jan; 96(1):9-13. PubMed ID: 5540002
    [No Abstract]   [Full Text] [Related]  

  • 17. The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease.
    Bell DS
    South Med J; 2009 Oct; 102(10):991-2. PubMed ID: 19738529
    [No Abstract]   [Full Text] [Related]  

  • 18. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
    Chavez-Tapia NC; Tiribelli C
    Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.